Cargando…
Measuring antigen expression of cancer cell lines and circulating tumour cells
When evaluating EpCAM-based enrichment technologies for circulating tumour cells (CTCs), the cell lines used should closely resemble real CTCs, meaning the EpCAM expression of CTCs needs to be known, but also the EpCAM expression of cell lines at different institutions and times is important. As the...
Autores principales: | Mentink, Anouk, Isebia, Khrystany T., Kraan, Jaco, Terstappen, Leon W. M. M., Stevens, Michiel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10101999/ https://www.ncbi.nlm.nih.gov/pubmed/37055551 http://dx.doi.org/10.1038/s41598-023-33179-y |
Ejemplares similares
-
Characterizing Circulating Tumor Cells and Tumor-Derived Extracellular Vesicles in Metastatic Castration-Naive and Castration-Resistant Prostate Cancer Patients
por: Isebia, Khrystany T., et al.
Publicado: (2022) -
Liquid Biopsy Based Circulating Biomarkers in Metastatic Prostate Cancer
por: Dathathri, Eshwari, et al.
Publicado: (2022) -
Optimal Halbach Configuration for Flow-through Immunomagnetic CTC Enrichment
por: Stevens, Michiel, et al.
Publicado: (2021) -
Detection of circulating tumor cells in blood of pancreatic ductal adenocarcinoma patients
por: Mayado, Andrea, et al.
Publicado: (2020) -
mFast‐SeqS‐based aneuploidy score in circulating cell‐free DNA is a prognostic biomarker in prostate cancer
por: Isebia, Khrystany T., et al.
Publicado: (2023)